Can I get it?
Not for this use. GHRP-6 has no EU authorisation for it, so it cannot be prescribed or dispensed here for that purpose.
Why buying it online is risky
GHRP-6 · Graz
GHRP-6 in Graz.
Not something we can prescribe. Our doctors can review your case for an EU-approved treatment instead.
Full refund if a review is not approved
NOT AVAILABLE TODAY
Hi-Doctor does not prescribe GHRP-6.
Our licensed doctors currently focus on three areas with solid clinical evidence and a clear EU regulatory framework. We extend the catalogue as specialists join and regulation allows. GHRP-6 is outside the current scope.
Buying GHRP-6 online without a valid prescription carries counterfeiting and toxicity risks. Always consult a licensed healthcare professional.
IN PLAIN TERMS
What GHRP-6 is, and how to get treatment
GHRP-6 is a laboratory-made peptide that switches on the ghrelin receptor, which triggers the pituitary gland to release growth hormone and also causes a strong increase in hunger. It has never been authorised as a medicine in the European Union or anywhere else, and no doctor can prescribe it. There is no completed human trial showing it is safe or effective for the muscle-building and "anti-ageing" uses it is sold for, and regulators have flagged effects on cortisol and blood sugar. It is supplied online as a research chemical made outside medicines manufacturing rules, so its contents and purity cannot be verified.
GHRP-6 has no EU marketing authorisation for this use. It may be an approved medicine for something else, or approved in another country — but not something a doctor here can prescribe for this.
What can I take instead?
Our doctors review every option and recommend what fits your history and goals.
What do the studies show?
Every trial behind GHRP-6 is listed below with how many people took part and whether the results are peer-reviewed or a company announcement.
Jump to the studiesWHAT WE DO COVER
If your question fits one of these three areas, a licensed doctor reviews it in less than 2 hours on average for €35.
TREATMENTS
Three categories, one process.
Choose what fits. The journey is identical.
ONGOING PLANWeight loss
A medical consultation on your weight goal. Treatment if appropriate.
€25/month28-day treatment cycle
Explore weight lossONE-OFFSexual health
An absolutely discreet consultation for intimate concerns.
€35 one-offFull refund if not approved
Explore sexual healthONGOING PLANHair growth
Medical assessment and tailored treatment for hair loss.
€15/monthBilled €45 every 90 days
Explore hair growthLicensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
VERIFIED EVIDENCE
GHRP-6: evidence and regulatory guide.
WHAT IT IS
How it works
A laboratory-made peptide that switches on the ghrelin receptor, which makes the pituitary gland release growth hormone and also produces a strong increase in appetite.
- GHS-R1a (ghrelin receptor)
DEVELOPMENT STAGE
Not marketed in the EU
Sources
Last reviewed 2026-07-27
- FDA — Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Growth hormone releasing peptide-6 (GHRP-6), 503B category 2, added 29 September 2023; page current as of 22 April 2026)
- ClinicalTrials.gov — intervention search for GHRP-6 (no registered studies)
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding — J Sports Med Phys Fitness 2026;66(7):880-885
- EMA — medicines database (no authorised EU medicine contains GHRP-6; checked against the EMA medicine list generated 27 July 2026)
NAMED SAFETY SIGNALS
What has been reported with GHRP-6.
Effects on cortisol and blood sugar
The US Food and Drug Administration states that available data "reveal safety concerns including potential effect on cortisol and increase in blood glucose due to decreases in insulin sensitivity".
Placed on the FDA's safety-risk list
GHRP-6 was added on 29 September 2023 to category 2 of the FDA's interim bulk drug substances policy — substances that may present significant safety risks — and remains listed there.
Impurity and immunogenicity risk
The FDA notes preparations "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities".
No registered human efficacy trials
A search of the public trials register returns no registered clinical trial of GHRP-6 as an intervention. There is no completed human trial supporting the uses it is sold for.
UNAPPROVED PRODUCTS ONLINE
Why buying GHRP-6 online is not a shortcut.
No doctor in the EU can prescribe it for this use — including ours. It may be authorised in another country, or for a different condition.
Check the EU common logo
A legitimate online pharmacy in the EU must display the common logo linked to its national register. The logo is a verification check; it cannot make an unapproved medicine legal.
How the EU common logo worksHOW IT WORKS · 5 STEPS
Five steps. No waiting room.
From the online consultation to ongoing follow-up — without leaving home.
- 5 minutes
Start your online visit
Answer a 5-minute health questionnaire from home.
- Less than 2 hours
A doctor reviews your case
A licensed doctor reviews your answers and replies personally.
- Refund guarantee
Review and payment
If not approved, we refund your €35 one-off in full.
- EU pharmacies
Collect treatment from the pharmacy
Collect it at any EU pharmacy with your e-prescription.
- 4-week check-in
Ongoing support
Private chat, 4-week check-in, simple prescription renewal.
NOTIFY ME
We'll tell you when we add new treatments.
We only use your email for this notification. You can opt out at any time.
FREQUENTLY ASKED QUESTIONS